GCP
NBP

GSA Capital Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

GSA Capital Partners’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-272,193
Closed -$455K – 1798
2024
Q2 		$455K Sell
272,193
-160,428
-37% -$287K 0.03% 1024
2024
Q1 		$805K Sell
432,621
-105,498
-20% -$194K 0.06% 587
2023
Q4 		$1.02M Buy
538,119
+342,573
+175% +$512K 0.09% 381
2023
Q3 		$258K Buy
195,546
+66,160
+51% +$145K 0.02% 1156
2023
Q2 		$387K Buy
129,386
+32,831
+34% +$105K 0.04% 896
2023
Q1 		$334K Sell
96,555
-120,856
-56% -$585K 0.03% 963
2022
Q4 		$909K Buy
217,411
+190,012
+693% +$719K 0.11% 259
2022
Q3 		$110K Buy
27,399
+9,204
+51% +$69.8K 0.01% 1349
2022
Q2 		$206K Buy
18,195
+486
+3% +$5.83K 0.03% 1057
2022
Q1 		$288K Buy
+17,709
New +$454K 0.04% 920
2021
Q3 		– Sell
-8,731
Closed -$733K – 1593
2021
Q2 		$733K Buy
+8,731
New +$576K 0.08% 390

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
EPL
EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

GSA Capital Partners's NBP Position: Q3 2024 in Review

GSA Capital Partners sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2024, closing a stake of 272,193 shares — an estimated $455K sold.

GSA Capital Partners first reported a position in NBP in Q2 2021 and held it in 11 quarters. The position peaked at $1.02M in Q4 2023. 28 funds tracked by Wall St. Rank hold NBP as of Q3 2024.

  • GSA Capital Partners reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • GSA Capital Partners sold 272,193 NovaBridge Biosciences American Depositary Shares shares in Q3 2024, an estimated $455K.
  • GSA Capital Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 11 quarters.
  • GSA Capital Partners's NovaBridge Biosciences American Depositary Shares position peaked at $1.02M in Q4 2023.
  • 28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2024.

Based on GSA Capital Partners's 13F filing for Q3 2024, filed 5 Nov 2024.